<?xml version="1.0" encoding="UTF-8"?>
<p>Nevertheless, measles remains an important cause of death among young children in Africa, even though there is a reliable, effective, inexpensive vaccine [
 <xref rid="pone.0213735.ref003" ref-type="bibr">3</xref>]. The fourth Millennium Development Goal is to eradicate measles by 2020 in all regions of the world, with a strategy based on strengthened vaccination services, introduction of a booster dose, strengthening of surveillance systems by laboratory confirmation of suspected cases and improving the care of patients [
 <xref rid="pone.0213735.ref002" ref-type="bibr">2</xref>–
 <xref rid="pone.0213735.ref004" ref-type="bibr">4</xref>]. This WHO-recommended strategy was adopted by the Central African Republic (CAR) and implemented in the programme of integrated disease surveillance and response. Since 1979, one dose of the vaccine against measles has been administered free of charge to infants &lt; 9 months in the Expanded Programme on Immunization introduced in the CAR by WHO and UNICEF. The mean coverage with the vaccine between 2007 and 2015 was, however, only 49% (25–59%), and many suspected cases of measles are reported throughout the country each year by the surveillance programme [
 <xref rid="pone.0213735.ref005" ref-type="bibr">5</xref>]. Since 2007, when case-by-case monitoring with standardized laboratory databases and monitoring, was set up, no assessment have been performed. Therfore, 9 years later it seemed appropriate to make a first assessment.
</p>
